Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from XR Immersive Tech Inc. ( (TSE:VRAI) ).
XR Immersive Tech Inc. has acquired Continuous Glucose Monitoring (CGM) technology from InsulinQ to expand its healthcare offerings. This acquisition aims to provide a more affordable and accessible CGM solution, leveraging AI and data analytics to enhance diabetes management and health optimization, thus expanding the company’s reach and impact in the U.S. healthcare sector.
More about XR Immersive Tech Inc.
XR Immersive Tech Inc. is a company involved in the healthcare industry, utilizing immersive technologies to address healthcare challenges since 2016. They have collaborated with organizations like Bayer and the FDA to enhance healthcare solutions.
YTD Price Performance: 182.35%
Average Trading Volume: 17,007
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$9.06M
For an in-depth examination of VRAI stock, go to TipRanks’ Stock Analysis page.